These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32050494)

  • 41. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.
    Gu J; Xu W; Lei L; Huang J; Feng X; Sun C; Du C; Zuo J; Li Y; Du T; Li L; Han W
    J Clin Microbiol; 2011 Jan; 49(1):111-7. PubMed ID: 21048011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
    Briers Y; Lavigne R
    Future Microbiol; 2015; 10(3):377-90. PubMed ID: 25812461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The application of the lytic domain of endolysin from Staphylococcus aureus bacteriophage in milk.
    Yan J; Yang R; Yu S; Zhao W
    J Dairy Sci; 2021 Mar; 104(3):2641-2653. PubMed ID: 33358804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel highly thermostable endolysin from Thermus scotoductus MAT2119 bacteriophage Ph2119 with amino acid sequence similarity to eukaryotic peptidoglycan recognition proteins.
    Plotka M; Kaczorowska AK; Stefanska A; Morzywolek A; Fridjonsson OH; Dunin-Horkawicz S; Kozlowski L; Hreggvidsson GO; Kristjansson JK; Dabrowski S; Bujnicki JM; Kaczorowski T
    Appl Environ Microbiol; 2014 Feb; 80(3):886-95. PubMed ID: 24271162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections.
    Younis W; Thangamani S; Seleem MN
    Curr Pharm Des; 2015; 21(28):4106-11. PubMed ID: 25961308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endolysin LysSA97 is synergistic with carvacrol in controlling Staphylococcus aureus in foods.
    Chang Y; Yoon H; Kang DH; Chang PS; Ryu S
    Int J Food Microbiol; 2017 Mar; 244():19-26. PubMed ID: 28063330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bacteriophages that infect Gram-negative bacteria as source of signal-arrest-release motif lysins.
    Gontijo MTP; Vidigal PMP; Lopez MES; Brocchi M
    Res Microbiol; 2021 Mar; 172(2):103794. PubMed ID: 33347948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of tilapia piscidin 3 (TP3) to protect against MRSA infection in mice with skin injuries.
    Huang HN; Chan YL; Hui CF; Wu JL; Wu CJ; Chen JY
    Oncotarget; 2015 May; 6(15):12955-69. PubMed ID: 25992774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beta-defensin derived cationic antimicrobial peptides with potent killing activity against gram negative and gram positive bacteria.
    Yang M; Zhang C; Zhang MZ; Zhang S
    BMC Microbiol; 2018 Jun; 18(1):54. PubMed ID: 29871599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthetic antimicrobial peptides as enhancers of the bacteriolytic action of staphylococcal phage endolysins.
    Gouveia A; Pinto D; Veiga H; Antunes W; Pinho MG; São-José C
    Sci Rep; 2022 Jan; 12(1):1245. PubMed ID: 35075218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T4 lysozyme fused with cellulose-binding module for antimicrobial cellulosic wound dressing materials.
    Abouhmad A; Mamo G; Dishisha T; Amin MA; Hatti-Kaul R
    J Appl Microbiol; 2016 Jul; 121(1):115-25. PubMed ID: 27028513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Broad Bactericidal Activity of the
    Antonova NP; Vasina DV; Lendel AM; Usachev EV; Makarov VV; Gintsburg AL; Tkachuk AP; Gushchin VA
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30901901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus.
    Al-Qawasmeh RA; Huesca M; Nedunuri V; Peralta R; Wright J; Lee Y; Young A
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3518-20. PubMed ID: 20483613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential of combination therapy of endolysin MR-10 and minocycline in treating MRSA induced systemic and localized burn wound infections in mice.
    Chopra S; Harjai K; Chhibber S
    Int J Med Microbiol; 2016 Dec; 306(8):707-716. PubMed ID: 27616281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydrophobicity-Modulated Small Antibacterial Molecule Eradicates Biofilm with Potent Efficacy against Skin Infections.
    Konai MM; Barman S; Issa R; MacNeil S; Adhikary U; De K; Monk PN; Haldar J
    ACS Infect Dis; 2020 Apr; 6(4):703-714. PubMed ID: 32058691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2010 and March 2011].
    Shinagawa N; Taniguchi M; Hirata K; Furuhata T; Fukuhara K; Mizugucwi T; Osanai H; Yanai Y; Hata F; Kihara C; Sasaki K; Oono K; Nakamura M; Shibuya H; Hasegawa I; Kimura M; Watabe K; Kobayashi Y; Yamaue H; Hirono S; Takesue Y; Fujiwara T; Shinoura S; Kimura H; Hoshikawa T; Oshima H; Aikawa N; Sasaki J; Suzuki M; Sekine K; Abe S; Takeyama H; Wakasugi T; Mashita K; Tanaka M; Mizuno A; Ishikawa M; Iwai A; Saito T; Muramoto M; Kubo S; Lee S; Fukuhara K; Iwagaki H; Tokunaga N; Sueda T; Hiyama E; Murakami Y; Ohge H; Uemura K; Tsumura H; Kanehiro T; Takeuchi H; Tanakaya K; Iwasaki M
    Jpn J Antibiot; 2014 Oct; 67(5):293-334. PubMed ID: 25549405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacteriophage lytic enzymes: novel anti-infectives.
    Fischetti VA
    Trends Microbiol; 2005 Oct; 13(10):491-6. PubMed ID: 16125935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel cysteine-free venom peptide with strong antimicrobial activity against antibiotics-resistant pathogens from the scorpion Opistophthalmus glabrifrons.
    Bao A; Zhong J; Zeng XC; Nie Y; Zhang L; Peng ZF
    J Pept Sci; 2015 Oct; 21(10):758-64. PubMed ID: 26251012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.